CeriBell (CBLL) Competitors $11.67 -0.28 (-2.34%) Closing price 04:00 PM EasternExtended Trading$11.68 +0.01 (+0.09%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CBLL vs. CNMD, NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, and IRMDShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry. CeriBell vs. Its Competitors CONMED NovoCure SS Innovations International Cadre BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed CONMED (NYSE:CNMD) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership. Do analysts rate CNMD or CBLL? CONMED currently has a consensus price target of $59.80, indicating a potential upside of 13.41%. CeriBell has a consensus price target of $32.14, indicating a potential upside of 175.43%. Given CeriBell's stronger consensus rating and higher possible upside, analysts clearly believe CeriBell is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, CNMD or CBLL? CONMED has higher revenue and earnings than CeriBell. CeriBell is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.33B1.23$132.42M$3.5314.94CeriBell$65.44M6.54-$40.46M-$2.99-3.90 Is CNMD or CBLL more profitable? CONMED has a net margin of 8.31% compared to CeriBell's net margin of -63.83%. CONMED's return on equity of 14.43% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CONMED8.31% 14.43% 6.05% CeriBell -63.83%-48.42%-28.50% Does the media prefer CNMD or CBLL? In the previous week, CONMED had 6 more articles in the media than CeriBell. MarketBeat recorded 8 mentions for CONMED and 2 mentions for CeriBell. CeriBell's average media sentiment score of 1.79 beat CONMED's score of 0.55 indicating that CeriBell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryCONMED beats CeriBell on 8 of the 13 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CBLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$427.82M$10.59B$5.70B$10.26BDividend YieldN/A1.86%5.72%4.60%P/E Ratio-3.9021.3975.8826.53Price / Sales6.5428.60492.67165.78Price / CashN/A25.0025.8129.90Price / Book2.193.4212.836.32Net Income-$40.46M$212.47M$3.28B$270.12M7 Day Performance-1.60%-1.00%0.17%2.12%1 Month Performance-5.20%2.17%4.54%6.31%1 Year PerformanceN/A-10.94%68.32%25.51% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell2.5382 of 5 stars$11.67-2.3%$32.14+175.4%N/A$427.82M$65.44M-3.90N/APositive NewsCNMDCONMED4.2404 of 5 stars$53.78-2.2%$59.80+11.2%-31.3%$1.70B$1.31B15.233,900Insider TradeNVCRNovoCure4.2612 of 5 stars$12.60+2.6%$28.79+128.5%-31.5%$1.37B$605.22M-8.081,488News CoveragePositive NewsGap UpSSIISS Innovations InternationalN/A$6.14-12.3%N/AN/A$1.36B$20.65M0.004News CoverageHigh Trading VolumeCDRECadre2.8383 of 5 stars$31.83-0.5%$31.50-1.0%-8.5%$1.30B$567.56M33.862,284Positive NewsAnalyst UpgradeBLFSBioLife Solutions2.6045 of 5 stars$26.22-0.9%$31.29+19.3%+2.7%$1.27B$93.47M-218.48440News CoveragePositive NewsESTAEstablishment Labs2.2927 of 5 stars$38.24-2.0%$56.50+47.8%-16.7%$1.13B$166.02M-12.541,018Positive NewsMDXGMiMedx Group3.4971 of 5 stars$7.17+0.4%$12.00+67.4%+12.1%$1.06B$348.88M34.14870Positive NewsPLSEPulse Biosciences4.2397 of 5 stars$15.04-0.5%$22.00+46.3%-15.0%$1.02B$700K-14.32140News CoveragePositive NewsInsider TradeINMDInMode2.8772 of 5 stars$15.28+2.0%$18.04+18.1%-12.8%$946.87M$401.56M6.19480Positive NewsIRMDiRadimed4.8043 of 5 stars$71.85-0.2%$72.00+0.2%+47.7%$915.36M$73.24M44.35110Positive NewsShort Interest ↓ Related Companies and Tools Related Companies CONMED Alternatives NovoCure Alternatives SS Innovations International Alternatives Cadre Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives MiMedx Group Alternatives Pulse Biosciences Alternatives InMode Alternatives iRadimed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBLL Stock Alerts